American Marconi Wireless News - Baptist Hospital Enhances Patient Safety and Air Quality with Good Salt(TM) Life's ByoCart(TM) Disinfection System

ByoCart™: Integrated Surface and Air Protection

Baptist Hospital, recognized for its nationally ranked institutes and Magnet® designation for nursing excellence, selected the ByoCart Disinfection System, Good Salt Life's proprietary institutional solution designed for large-scale facilities such as hospitals, schools, and public venues, to further strengthen its patient and staff safety initiatives. The system's advanced induction-charged air-scrubbing technology provides consistent, high-efficacy coverage while capturing airborne contaminants that contribute to poor indoor air quality. This dual-action process disinfects surfaces and helps remove contaminants from the atmosphere, providing complete, high-efficacy disinfection coverage.

"Baptist Hospital's adoption of the ByoCart system demonstrates the growing demand for next-generation biosafety technology in healthcare," said Zach O'Shea, President and CEO of NDT Pharmaceuticals. "ByoCart not only ensures consistent surface disinfection but also measurably enhances air quality, helping hospitals achieve higher safety standards, operational efficiency, and long-term value."

Key Benefits of the ByoCart™ System:

• Comprehensive Protection: Simultaneously disinfects surfaces and improves air quality, providing dual-layer safety in high-demand environments.

• Superior Coverage: Precision application ensures even treatment of complex and hard-to-reach surfaces often missed by manual cleaning.

• Operational Efficiency: Rapid deployment and wide-area coverage shorten room turnover times, optimize staff resources, and reduce downtime.

• Consistency and Reliability: Automated dosing removes human variability, ensuring uniform performance aligned with healthcare sanitation standards.

• Seamless Integration: Fully compatible with existing EPA-approved disinfectantformulations, enabling effortless adoption without altering supply chains.

The deployment at Baptist Hospital represents a strategic milestone in NDT Pharmaceuticals' expansion within the healthcare biosafety market, reinforcing its reputation as a trusted provider of scalable, technology-driven infection prevention solutions.

About NDT Pharmaceuticals, Inc. (OTC:NDTP)

NDT Pharmaceuticals, Inc. is a publicly traded company focused on advancing innovative consumer health and wellness solutions. Through its subsidiary, Good Salt Life, the Company has expanded its strategic direction into sustainable, science-driven products that promote healthier living. The Company is committed to building value through investments in sustainable, science-driven brands that protect people, pets, and the planet while aligning with growing consumer demand for eco-friendly and health-conscious alternatives.

About Good Salt™ Life, Inc.

Good Salt Life is dedicated to promoting vitality through eco-friendly, nature-derived products that support healthier living environments. With a focus on innovation and sustainability, the company offers safe and effective solutions for home, pet, personal care, and animal health. Through strategic partnerships, including collaborations in the B2B animal health sector, Good Salt Life continues to drive advancements that benefit both people and animals. For more information, visit www.goodsaltlife.com.

Forward-Looking Statements

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's current expectations and speak only as of the date of this release. Actual results may differ materially from the Company's current expectations. Except as required by law, the Company does not undertake any responsibility to revise or update any forward-looking statements.

Contact:

[email protected]

SOURCE: NDT Pharmaceuticals Inc.

View the original press release on ACCESS Newswire

L.Mason--AMWN